News
PLYGF
43.00
NaN%
--
PolyPeptide Group AG (PPGN) Gets a Buy from RBC Capital
TipRanks · 4d ago
PolyPeptide price target raised to CHF 38 from CHF 35 at Berenberg
TipRanks · 06/16 16:17
PolyPeptide price target raised to CHF 40 from CHF 33 at Barclays
TipRanks · 06/16 16:06
Barclays Sticks to Its Buy Rating for PolyPeptide Group AG (PPGN)
TipRanks · 06/16 09:48
UBS Reaffirms Their Buy Rating on PolyPeptide Group AG (PPGN)
TipRanks · 05/07 09:07
Hims & Hers on track to extend gains as RFK Jr. seeks to loosen peptide regulations
Seeking Alpha · 04/16 09:15
FDA sets up AdCom meeting to decide on lifting restrictions on certain peptides
Seeking Alpha · 04/15 17:42
PolyPeptide Confirms Strategic Review Amid Takeover Speculation
TipRanks · 04/14 05:33
Midday Fly By: Goldman reports Q1 beat, Baker Hughes to sell Waygate
TipRanks · 04/13 16:09
PolyPeptide is attracting takeover interest from EQT, KKR, Bloomberg says
TipRanks · 04/13 10:26
RBC Capital Keeps Their Buy Rating on PolyPeptide Group AG (PPGN)
TipRanks · 04/13 10:10
RBC Capital Sticks to Its Buy Rating for PolyPeptide Group AG (PPGN)
TipRanks · 04/10 07:06
PolyPeptide shareholders back all proposals at 2026 AGM
TipRanks · 04/08 16:35
UBS Remains a Buy on PolyPeptide Group AG (PPGN)
TipRanks · 04/07 09:05
PolyPeptide Group AG (PPGN) Gets a Buy from Berenberg Bank
TipRanks · 03/31 06:28
PolyPeptide expands EUR 200 million credit line to back growth and capacity plans
TipRanks · 03/19 06:34
PolyPeptide Sets 2026 AGM to Confirm Board and Approve 2025 Reports
TipRanks · 03/17 06:33
UBS Reaffirms Their Buy Rating on PolyPeptide Group AG (PPGN)
TipRanks · 03/13 09:49
PolyPeptide lifts revenue and margins as peptide demand fuels major capacity build-out
TipRanks · 03/12 06:03
PolyPeptide Reports Strong Preliminary 2025 Results With Higher Revenue And Profit
NASDAQ · 01/19 18:18
More
Webull provides a variety of real-time PLYGF stock news. You can receive the latest news about PolyPeptide Group through multiple platforms. This information may help you make smarter investment decisions.
About PLYGF
Polypeptide Group AG is a Switzerland-based Contract Development & Manufacturing Organization (CDMO) focusing on proprietary and generic GMP-grade peptides used by pharmaceutical and biotech companies in approved pharmaceutical products, drugs in clinical development as well as in generic products.